nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—hypertension—obesity	0.595	1	CtDrD
Mecamylamine—CHRNA3—Bupropion—obesity	0.344	1	CbGbCtD
Mecamylamine—Mydriasis—Diethylpropion—obesity	0.00218	0.0358	CcSEcCtD
Mecamylamine—Erectile dysfunction—Methamphetamine—obesity	0.00161	0.0264	CcSEcCtD
Mecamylamine—Urinary retention—Phenylpropanolamine—obesity	0.00144	0.0237	CcSEcCtD
Mecamylamine—Dizziness postural—Topiramate—obesity	0.00141	0.0231	CcSEcCtD
Mecamylamine—Erectile dysfunction—Phentermine—obesity	0.00116	0.019	CcSEcCtD
Mecamylamine—Urinary retention—Cimetidine—obesity	0.00114	0.0188	CcSEcCtD
Mecamylamine—Tremor—Methamphetamine—obesity	0.00114	0.0187	CcSEcCtD
Mecamylamine—Tremor—Benzphetamine—obesity	0.0011	0.0181	CcSEcCtD
Mecamylamine—Vision blurred—Phendimetrazine—obesity	0.00101	0.0166	CcSEcCtD
Mecamylamine—Erectile dysfunction—Diethylpropion—obesity	0.00101	0.0165	CcSEcCtD
Mecamylamine—Tremor—Phendimetrazine—obesity	0.001	0.0165	CcSEcCtD
Mecamylamine—Mydriasis—Bupropion—obesity	0.000967	0.0159	CcSEcCtD
Mecamylamine—Glossitis—Sibutramine—obesity	0.00096	0.0158	CcSEcCtD
Mecamylamine—Erectile dysfunction—Cimetidine—obesity	0.000956	0.0157	CcSEcCtD
Mecamylamine—Anorexia—Benzphetamine—obesity	0.000913	0.015	CcSEcCtD
Mecamylamine—Vision blurred—Phenylpropanolamine—obesity	0.000861	0.0141	CcSEcCtD
Mecamylamine—Tremor—Phenylpropanolamine—obesity	0.000856	0.0141	CcSEcCtD
Mecamylamine—Constipation—Methamphetamine—obesity	0.000849	0.0139	CcSEcCtD
Mecamylamine—Glossitis—Bupropion—obesity	0.000837	0.0137	CcSEcCtD
Mecamylamine—Decreased appetite—Benzphetamine—obesity	0.000832	0.0137	CcSEcCtD
Mecamylamine—Anorexia—Phendimetrazine—obesity	0.000832	0.0137	CcSEcCtD
Mecamylamine—Tremor—Phentermine—obesity	0.000819	0.0135	CcSEcCtD
Mecamylamine—Decreased appetite—Phendimetrazine—obesity	0.000759	0.0125	CcSEcCtD
Mecamylamine—Constipation—Phendimetrazine—obesity	0.000746	0.0123	CcSEcCtD
Mecamylamine—Vision blurred—Diethylpropion—obesity	0.000717	0.0118	CcSEcCtD
Mecamylamine—Tremor—Diethylpropion—obesity	0.000712	0.0117	CcSEcCtD
Mecamylamine—Libido decreased—Sibutramine—obesity	0.000692	0.0114	CcSEcCtD
Mecamylamine—Convulsion—Diethylpropion—obesity	0.000659	0.0108	CcSEcCtD
Mecamylamine—Dizziness—Methamphetamine—obesity	0.000657	0.0108	CcSEcCtD
Mecamylamine—Constipation—Phenylpropanolamine—obesity	0.000637	0.0105	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Sibutramine—obesity	0.000637	0.0105	CcSEcCtD
Mecamylamine—Dizziness—Benzphetamine—obesity	0.000633	0.0104	CcSEcCtD
Mecamylamine—Mydriasis—Topiramate—obesity	0.000616	0.0101	CcSEcCtD
Mecamylamine—Fatigue—Phentermine—obesity	0.000615	0.0101	CcSEcCtD
Mecamylamine—Urinary retention—Sibutramine—obesity	0.00061	0.01	CcSEcCtD
Mecamylamine—Constipation—Phentermine—obesity	0.00061	0.01	CcSEcCtD
Mecamylamine—Libido decreased—Bupropion—obesity	0.000603	0.00991	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Sibutramine—obesity	0.000586	0.00963	CcSEcCtD
Mecamylamine—Dizziness—Phendimetrazine—obesity	0.000577	0.00948	CcSEcCtD
Mecamylamine—Nausea—Benzphetamine—obesity	0.000569	0.00934	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Bupropion—obesity	0.000555	0.00912	CcSEcCtD
Mecamylamine—Glossitis—Topiramate—obesity	0.000533	0.00875	CcSEcCtD
Mecamylamine—Urinary retention—Bupropion—obesity	0.000532	0.00874	CcSEcCtD
Mecamylamine—Constipation—Diethylpropion—obesity	0.000531	0.00872	CcSEcCtD
Mecamylamine—Nausea—Phendimetrazine—obesity	0.000518	0.00851	CcSEcCtD
Mecamylamine—Asthenia—Phentermine—obesity	0.000512	0.00841	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Bupropion—obesity	0.000511	0.0084	CcSEcCtD
Mecamylamine—Erectile dysfunction—Sibutramine—obesity	0.000511	0.00839	CcSEcCtD
Mecamylamine—Fatigue—Cimetidine—obesity	0.000509	0.00836	CcSEcCtD
Mecamylamine—Constipation—Cimetidine—obesity	0.000505	0.00829	CcSEcCtD
Mecamylamine—Dizziness—Phenylpropanolamine—obesity	0.000493	0.0081	CcSEcCtD
Mecamylamine—Vomiting—Phenylpropanolamine—obesity	0.000474	0.00779	CcSEcCtD
Mecamylamine—Dizziness—Phentermine—obesity	0.000472	0.00775	CcSEcCtD
Mecamylamine—Vomiting—Phentermine—obesity	0.000454	0.00745	CcSEcCtD
Mecamylamine—Erectile dysfunction—Bupropion—obesity	0.000445	0.00732	CcSEcCtD
Mecamylamine—Nausea—Phenylpropanolamine—obesity	0.000443	0.00727	CcSEcCtD
Mecamylamine—Nausea—Phentermine—obesity	0.000424	0.00696	CcSEcCtD
Mecamylamine—Asthenia—Cimetidine—obesity	0.000424	0.00696	CcSEcCtD
Mecamylamine—Dizziness—Diethylpropion—obesity	0.00041	0.00674	CcSEcCtD
Mecamylamine—Vomiting—Diethylpropion—obesity	0.000395	0.00648	CcSEcCtD
Mecamylamine—Dizziness—Cimetidine—obesity	0.00039	0.00641	CcSEcCtD
Mecamylamine—Libido decreased—Topiramate—obesity	0.000384	0.00632	CcSEcCtD
Mecamylamine—Vision blurred—Orlistat—obesity	0.000376	0.00618	CcSEcCtD
Mecamylamine—Vomiting—Cimetidine—obesity	0.000375	0.00617	CcSEcCtD
Mecamylamine—Nausea—Diethylpropion—obesity	0.000369	0.00606	CcSEcCtD
Mecamylamine—Vision blurred—Sibutramine—obesity	0.000364	0.00598	CcSEcCtD
Mecamylamine—Tremor—Sibutramine—obesity	0.000362	0.00595	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Topiramate—obesity	0.000354	0.00581	CcSEcCtD
Mecamylamine—Nausea—Cimetidine—obesity	0.000351	0.00576	CcSEcCtD
Mecamylamine—Syncope—Sibutramine—obesity	0.000347	0.00569	CcSEcCtD
Mecamylamine—Convulsion—Orlistat—obesity	0.000346	0.00568	CcSEcCtD
Mecamylamine—Loss of consciousness—Sibutramine—obesity	0.00034	0.00558	CcSEcCtD
Mecamylamine—Urinary retention—Topiramate—obesity	0.000339	0.00557	CcSEcCtD
Mecamylamine—Convulsion—Sibutramine—obesity	0.000335	0.0055	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Topiramate—obesity	0.000326	0.00535	CcSEcCtD
Mecamylamine—Vision blurred—Bupropion—obesity	0.000318	0.00522	CcSEcCtD
Mecamylamine—Tremor—Bupropion—obesity	0.000316	0.00519	CcSEcCtD
Mecamylamine—Shock—Sibutramine—obesity	0.00031	0.0051	CcSEcCtD
Mecamylamine—Syncope—Bupropion—obesity	0.000302	0.00496	CcSEcCtD
Mecamylamine—Anorexia—Sibutramine—obesity	0.000301	0.00494	CcSEcCtD
Mecamylamine—Loss of consciousness—Bupropion—obesity	0.000296	0.00487	CcSEcCtD
Mecamylamine—Paraesthesia—Orlistat—obesity	0.000293	0.00481	CcSEcCtD
Mecamylamine—Convulsion—Bupropion—obesity	0.000292	0.0048	CcSEcCtD
Mecamylamine—Erectile dysfunction—Topiramate—obesity	0.000284	0.00466	CcSEcCtD
Mecamylamine—Decreased appetite—Orlistat—obesity	0.000283	0.00465	CcSEcCtD
Mecamylamine—Paraesthesia—Sibutramine—obesity	0.000283	0.00465	CcSEcCtD
Mecamylamine—Fatigue—Orlistat—obesity	0.000281	0.00462	CcSEcCtD
Mecamylamine—Decreased appetite—Sibutramine—obesity	0.000274	0.00451	CcSEcCtD
Mecamylamine—Shock—Bupropion—obesity	0.000271	0.00444	CcSEcCtD
Mecamylamine—Constipation—Sibutramine—obesity	0.00027	0.00443	CcSEcCtD
Mecamylamine—Anorexia—Bupropion—obesity	0.000262	0.00431	CcSEcCtD
Mecamylamine—Paraesthesia—Bupropion—obesity	0.000247	0.00406	CcSEcCtD
Mecamylamine—Decreased appetite—Bupropion—obesity	0.000239	0.00393	CcSEcCtD
Mecamylamine—Fatigue—Bupropion—obesity	0.000237	0.0039	CcSEcCtD
Mecamylamine—Constipation—Bupropion—obesity	0.000235	0.00386	CcSEcCtD
Mecamylamine—Asthenia—Orlistat—obesity	0.000234	0.00384	CcSEcCtD
Mecamylamine—Asthenia—Sibutramine—obesity	0.000226	0.00372	CcSEcCtD
Mecamylamine—Dizziness—Orlistat—obesity	0.000216	0.00354	CcSEcCtD
Mecamylamine—Dizziness—Sibutramine—obesity	0.000209	0.00343	CcSEcCtD
Mecamylamine—Vomiting—Orlistat—obesity	0.000207	0.0034	CcSEcCtD
Mecamylamine—Vision blurred—Topiramate—obesity	0.000202	0.00332	CcSEcCtD
Mecamylamine—Tremor—Topiramate—obesity	0.000201	0.0033	CcSEcCtD
Mecamylamine—Vomiting—Sibutramine—obesity	0.000201	0.0033	CcSEcCtD
Mecamylamine—Asthenia—Bupropion—obesity	0.000197	0.00324	CcSEcCtD
Mecamylamine—Nausea—Orlistat—obesity	0.000194	0.00318	CcSEcCtD
Mecamylamine—Syncope—Topiramate—obesity	0.000193	0.00316	CcSEcCtD
Mecamylamine—Loss of consciousness—Topiramate—obesity	0.000189	0.0031	CcSEcCtD
Mecamylamine—Nausea—Sibutramine—obesity	0.000187	0.00308	CcSEcCtD
Mecamylamine—Convulsion—Topiramate—obesity	0.000186	0.00306	CcSEcCtD
Mecamylamine—Dizziness—Bupropion—obesity	0.000182	0.00299	CcSEcCtD
Mecamylamine—Vomiting—Bupropion—obesity	0.000175	0.00287	CcSEcCtD
Mecamylamine—Shock—Topiramate—obesity	0.000172	0.00283	CcSEcCtD
Mecamylamine—Anorexia—Topiramate—obesity	0.000167	0.00274	CcSEcCtD
Mecamylamine—Nausea—Bupropion—obesity	0.000163	0.00268	CcSEcCtD
Mecamylamine—Paraesthesia—Topiramate—obesity	0.000157	0.00258	CcSEcCtD
Mecamylamine—Decreased appetite—Topiramate—obesity	0.000152	0.0025	CcSEcCtD
Mecamylamine—Fatigue—Topiramate—obesity	0.000151	0.00248	CcSEcCtD
Mecamylamine—Constipation—Topiramate—obesity	0.00015	0.00246	CcSEcCtD
Mecamylamine—Asthenia—Topiramate—obesity	0.000126	0.00207	CcSEcCtD
Mecamylamine—Dizziness—Topiramate—obesity	0.000116	0.0019	CcSEcCtD
Mecamylamine—Vomiting—Topiramate—obesity	0.000111	0.00183	CcSEcCtD
Mecamylamine—Nausea—Topiramate—obesity	0.000104	0.00171	CcSEcCtD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	1.4e-05	0.0577	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	1.31e-05	0.0538	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	8.74e-06	0.036	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	7.99e-06	0.0329	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	7.13e-06	0.0293	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ACADM—obesity	6.72e-06	0.0276	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GABRA6—obesity	6.57e-06	0.027	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SLC9A3—obesity	6.37e-06	0.0262	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GABRA6—obesity	6.01e-06	0.0247	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GABRA6—obesity	5.36e-06	0.0221	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—PPARGC1B—obesity	5.24e-06	0.0216	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GABRA6—obesity	5.03e-06	0.0207	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GLUL—obesity	4.68e-06	0.0193	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GABRA6—obesity	4.6e-06	0.0189	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GLUL—obesity	4.28e-06	0.0176	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GABRA6—obesity	4.11e-06	0.0169	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—PRKAR2B—obesity	3.89e-06	0.016	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GLUL—obesity	3.82e-06	0.0157	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CPT1A—obesity	3.75e-06	0.0154	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—GCK—obesity	3.66e-06	0.015	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GLUL—obesity	3.59e-06	0.0148	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TF—obesity	3.49e-06	0.0144	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC22A1—obesity	3.45e-06	0.0142	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GLUL—obesity	3.28e-06	0.0135	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—obesity	3.28e-06	0.0135	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—NTRK2—obesity	3.19e-06	0.0131	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC22A1—obesity	3.16e-06	0.013	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—KCNMA1—obesity	3.03e-06	0.0125	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ESR2—obesity	2.94e-06	0.0121	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GLUL—obesity	2.93e-06	0.012	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC22A1—obesity	2.82e-06	0.0116	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—KCNMA1—obesity	2.77e-06	0.0114	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	2.67e-06	0.011	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC22A1—obesity	2.64e-06	0.0109	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—AR—obesity	2.6e-06	0.0107	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—BCHE—obesity	2.55e-06	0.0105	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—KCNMA1—obesity	2.47e-06	0.0102	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—GNB3—obesity	2.45e-06	0.0101	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—PPARGC1A—obesity	2.45e-06	0.0101	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	2.44e-06	0.0101	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC22A1—obesity	2.42e-06	0.00995	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—obesity	2.38e-06	0.0098	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—BCHE—obesity	2.33e-06	0.00959	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL10—obesity	2.27e-06	0.00936	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	2.18e-06	0.00898	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC22A1—obesity	2.16e-06	0.00888	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—NR3C1—obesity	2.1e-06	0.00866	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—BCHE—obesity	2.08e-06	0.00856	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—COMT—obesity	2.04e-06	0.00839	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—obesity	2.01e-06	0.00828	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GNB3—obesity	2.01e-06	0.00827	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—BCHE—obesity	1.95e-06	0.00804	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	1.92e-06	0.00792	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—COMT—obesity	1.86e-06	0.00767	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GNB3—obesity	1.84e-06	0.00756	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—BCHE—obesity	1.79e-06	0.00735	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	1.76e-06	0.00724	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—COMT—obesity	1.66e-06	0.00684	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GNB3—obesity	1.64e-06	0.00675	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—BCHE—obesity	1.59e-06	0.00656	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	1.57e-06	0.00646	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—COMT—obesity	1.56e-06	0.00643	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GNB3—obesity	1.54e-06	0.00634	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—PRKCB—obesity	1.45e-06	0.00595	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—COMT—obesity	1.43e-06	0.00588	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GNB3—obesity	1.41e-06	0.00579	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—PRKCB—obesity	1.32e-06	0.00544	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—COMT—obesity	1.27e-06	0.00524	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GNB3—obesity	1.26e-06	0.00517	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—obesity	1.19e-06	0.00491	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—PRKCB—obesity	1.18e-06	0.00486	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—PRKCB—obesity	1.11e-06	0.00456	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—PRKCB—obesity	1.01e-06	0.00417	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—PRKCB—obesity	9.04e-07	0.00372	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TNF—obesity	8.65e-07	0.00356	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL6—obesity	6.98e-07	0.00287	CbGpPWpGaD
